Security key
14888U101
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)
CUSIP: 14888U101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,180,519
- Total 13F shares
- 101,339,025
- Share change
- +3,618,219
- Total reported value
- $2,199,165,165
- Price per share
- $21.70
- Number of holders
- 360
- Value change
- +$74,610,948
- Number of buys
- 204
- Number of sells
- 171
Report period
Q2 2025
Institutions
360
Top holders
10
CPRX full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
CATALYST PHARMACEUTICALS, INC. SEC filings
CATALYST PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14888U101
Recent filing periods:
Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
14%
from 13D/G
|
18,804,335
|
$456,005,131 | — | 31 Mar 2025 | |
| James E. Flynn |
13D/G
|
Deerfield Mgmt, L.P. |
2.6%
|
3,133,011
|
$74,033,050 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.9%
|
8,495,580
|
$206,017,816 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.5%
|
5,530,437
|
$134,113,097 | — | 31 Mar 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.8%
|
3,422,149
|
$82,987,113 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.5%
|
3,135,473
|
$76,035,220 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.4%
|
2,956,316
|
$71,690,663 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,765,556
|
$67,079,607 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
2,394,555
|
$58,067,988 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.8%
|
2,187,422
|
$53,046,404 | — | 31 Mar 2025 | |
| Fundsmith LLP |
13F
|
Company |
1.7%
|
2,151,274
|
$52,168,395 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.5%
|
1,811,475
|
$43,928,269 | — | 31 Mar 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.3%
|
1,598,360
|
$38,760,230 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,486,198
|
$36,040,302 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
1,326,771
|
$32,174,197 | — | 31 Mar 2025 | |
| Boston Partners |
13F
|
Company |
1%
|
1,275,325
|
$30,627,764 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.97%
|
1,199,627
|
$29,090,956 | — | 31 Mar 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.86%
|
1,061,323
|
$25,737,083 | — | 31 Mar 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.84%
|
1,035,029
|
$25,099,453 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.79%
|
977,623
|
$23,708,000 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.76%
|
934,612
|
$22,664,590 | — | 31 Mar 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.69%
|
854,367
|
$20,718,400 | — | 31 Mar 2025 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.64%
|
786,900
|
$19,082,325 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.62%
|
768,012
|
$17,185,168 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.62%
|
765,294
|
$18,558,380 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.62%
|
760,296
|
$18,437,178 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.62%
|
759,404
|
$18,415,547 | — | 31 Mar 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.59%
|
724,091
|
$17,559,207 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.58%
|
709,925
|
$17,215,677 | — | 31 Mar 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.57%
|
703,802
|
$17,067,000 | — | 31 Mar 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.56%
|
694,125
|
$16,832,531 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.56%
|
685,416
|
$16,621,338 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.5%
|
617,506
|
$14,974,521 | — | 31 Mar 2025 | |
| Swedbank AB |
13F
|
Company |
0.5%
|
616,132
|
$14,941,201 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.47%
|
573,637
|
$13,910,699 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.44%
|
539,782
|
$13,089,714 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.43%
|
526,569
|
$12,769,298 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.43%
|
526,297
|
$12,762,703 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.41%
|
506,445
|
$12,281,291 | — | 31 Mar 2025 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.4%
|
488,587
|
$11,848,235 | — | 31 Mar 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.38%
|
467,600
|
$11,339,300 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.36%
|
445,510
|
$10,803,617 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.36%
|
440,523
|
$10,682,683 | — | 31 Mar 2025 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0.34%
|
416,371
|
$10,096,997 | — | 31 Mar 2025 | |
| JW Asset Management, LLC |
13F
|
Company |
0.34%
|
413,392
|
$10,024,756 | — | 31 Mar 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.33%
|
410,762
|
$9,960,979 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.31%
|
381,184
|
$9,243,712 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.29%
|
352,534
|
$8,548,950 | — | 31 Mar 2025 | |
| New Vernon Capital Holdings II LLC |
13F
|
Company |
0.27%
|
327,860
|
$13,520,000 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.26%
|
319,879
|
$7,757,060 | — | 31 Mar 2025 |
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2025
As of 30 Jun 2025,
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by
360 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
101,339,025 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, DEERFIELD MANAGEMENT COMPANY, L.P., GEODE CAPITAL MANAGEMENT, LLC, Fundsmith LLP, GOLDMAN SACHS GROUP INC, and BANK OF AMERICA CORP /DE/.
This page lists
363
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
365
Q2 2025 holders
360
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.